Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology (2009) 9.51

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27

Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology (2010) 4.44

Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A (2002) 4.18

Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci (2008) 4.04

The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J (2001) 3.85

Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics (2011) 3.76

Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol (2005) 2.61

Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41

Neuraxial labor analgesia for vaginal delivery and its effects on childhood learning disabilities. Anesth Analg (2010) 2.31

Surgery and neurodevelopmental outcome of very low-birth-weight infants. JAMA Pediatr (2014) 2.18

Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology (2010) 2.08

Impact of anaesthetics and surgery on neurodevelopment: an update. Br J Anaesth (2013) 1.99

Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia. Mayo Clin Proc (2012) 1.95

Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci (2006) 1.94

Effects of intrathecal ketamine in the neonatal rat: evaluation of apoptosis and long-term functional outcome. Anesthesiology (2010) 1.89

Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88

Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys J (2000) 1.79

NMDA receptors activated by subventricular zone astrocytic glutamate are critical for neuroblast survival prior to entering a synaptic network. Neuron (2010) 1.78

Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents. J Cereb Blood Flow Metab (2010) 1.75

Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet (2009) 1.72

Clinical anesthesia causes permanent damage to the fetal guinea pig brain. Brain Pathol (2008) 1.71

Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol (2012) 1.70

Early childhood general anaesthesia exposure and neurocognitive development. Br J Anaesth (2010) 1.67

The dichotomy of NMDA receptor signaling. Neuroscientist (2007) 1.61

Ketamine-induced neuroapoptosis in the fetal and neonatal rhesus macaque brain. Anesthesiology (2012) 1.59

Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J Neurosci (2008) 1.58

Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia. Front Mol Neurosci (2008) 1.58

GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology (2011) 1.55

Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci (2008) 1.51

Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem (2009) 1.51

Ketamine alters the neurogenesis of rat cortical neural stem progenitor cells. Crit Care Med (2012) 1.50

Coupling of the NMDA receptor to neuroprotective and neurodestructive events. Biochem Soc Trans (2009) 1.50

Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort. Anesthesiology (2009) 1.47

Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth (2013) 1.47

High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology (2009) 1.46

Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ (2008) 1.44

Nitrative and oxidative stress in toxicology and disease. Toxicol Sci (2009) 1.44

Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42

Suppression of the intrinsic apoptosis pathway by synaptic activity. J Neurosci (2010) 1.40

Brain maturation in neonatal rodents is impeded by sevoflurane anesthesia. Anesthesiology (2015) 1.38

Timing versus duration: determinants of anesthesia-induced developmental apoptosis in the young mammalian brain. Ann N Y Acad Sci (2010) 1.37

General anesthesia causes long-lasting disturbances in the ultrastructural properties of developing synapses in young rats. Neurotox Res (2009) 1.37

Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull (2008) 1.37

General Anesthesia Causes Long-term Impairment of Mitochondrial Morphogenesis and Synaptic Transmission in Developing Rat Brain. Anesthesiology (2011) 1.36

Hypothermic neuroprotection. NeuroRx (2006) 1.36

Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther (2007) 1.35

Hypoxic-ischemic encephalopathy in the term infant. Clin Perinatol (2009) 1.35

Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci (2009) 1.33

Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology (2009) 1.33

Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc Natl Acad Sci U S A (2009) 1.29

NMDA receptor-dependent pattern transfer from afferents to postsynaptic cells and dendritic differentiation in the barrel cortex. Mol Cell Neurosci (2002) 1.26

Are anaesthetics toxic to the brain? Br J Anaesth (2011) 1.26

Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain. Neurobiol Dis (2008) 1.24

Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci (2012) 1.22

Compartmentalized NMDA receptor signalling to survival and death. J Physiol (2007) 1.21

Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A (2000) 1.21

Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol Dis (2008) 1.20

Neonatal seizures: an update on mechanisms and management. Clin Perinatol (2009) 1.19

NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci (2011) 1.18

A rice glutamate receptor-like gene is critical for the division and survival of individual cells in the root apical meristem. Plant Cell (2005) 1.18

Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects. Eur Arch Psychiatry Clin Neurosci (1999) 1.18

Validation of a preclinical spinal safety model: effects of intrathecal morphine in the neonatal rat. Anesthesiology (2010) 1.17

Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology (2009) 1.17

Effects of neonatal antiepileptic drug exposure on cognitive, emotional, and motor function in adult rats. J Pharmacol Exp Ther (2011) 1.14

Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol (2010) 1.14

GABAergic mechanism of propofol toxicity in immature neurons. J Neurosurg Anesthesiol (2008) 1.13

Neurotoxicity of general anesthetics: cause for concern? Anesthesiology (2009) 1.13

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology. Environ Health Perspect (2001) 1.13

From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc Natl Acad Sci U S A (2006) 1.13

Alcohol-induced neuroapoptosis in the fetal macaque brain. Neurobiol Dis (2010) 1.13

Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons. J Neurosci (2009) 1.11

N-methyl-D-aspartate receptor subunit changes after traumatic injury to the developing brain. J Neurotrauma (2006) 1.10

Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb Cortex (2008) 1.09

Response to neonatal anesthesia: effect of sex on anatomical and behavioral outcome. Neuroscience (2008) 1.08

Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain. Nat Commun (2014) 1.08

Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc Natl Acad Sci U S A (2005) 1.06

Postnatal binge-like alcohol exposure decreases dendritic complexity while increasing the density of mature spines in mPFC Layer II/III pyramidal neurons. Synapse (2010) 1.06

Potential mechanism of cell death in the developing rat brain induced by propofol anesthesia. Int J Dev Neurosci (2008) 1.05

Isoflurane does not affect brain cell death, hippocampal neurogenesis, or long-term neurocognitive outcome in aged rats. Anesthesiology (2010) 1.04

Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS One (2013) 1.04

Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat. Neuropharmacology (2012) 1.04

NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders. Neurosci Biobehav Rev (2012) 1.03

Isoflurane impairs immature astroglia development in vitro: the role of actin cytoskeleton. J Neuropathol Exp Neurol (2011) 1.03

NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice. J Clin Invest (2010) 1.03

Abnormal angular gyrus asymmetry in schizophrenia. Am J Psychiatry (2000) 1.02

Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab (2011) 1.02

Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect (2000) 1.01

Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits. Psychopharmacology (Berl) (2004) 1.00

Cell age-specific vulnerability of neurons to anesthetic toxicity. Ann Neurol (2013) 1.00

Brevetoxin activation of voltage-gated sodium channels regulates Ca dynamics and ERK1/2 phosphorylation in murine neocortical neurons. J Neurochem (2004) 0.99

Electroacupuncture enhances cell proliferation and neuronal differentiation in young rat brains. Neurol Sci (2010) 0.99

Molecular approaches to improving general anesthetics. Anesthesiol Clin (2010) 0.98

Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol (2015) 0.97

Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology (2009) 0.97

Genetic deletion of CD36 enhances injury after acute neonatal stroke. Ann Neurol (2012) 0.97

Cell biology in neuroscience: Death of developing neurons: new insights and implications for connectivity. J Cell Biol (2013) 0.97

Dizocilpine (MK-801) induces distinct changes of N-methyl-D-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex. Int J Neuropsychopharmacol (2009) 0.97

General anesthetics in pediatric anesthesia: influences on the developing brain. Curr Drug Targets (2012) 0.96

Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. PLoS One (2007) 0.96

Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science (2000) 5.57

Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol (1986) 3.18

Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science (1969) 3.08

Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73

Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med (1998) 2.71

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther (2009) 2.54

Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46

Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med (2000) 2.34

Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol (1995) 2.29

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol (1994) 2.20

Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury. Exp Neurol (2007) 2.18

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology (1999) 1.97

Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88

Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol (1998) 1.81

Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med (1998) 1.79

Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ (2003) 1.72

Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry (1995) 1.71

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.71

Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron (2001) 1.70

Glycine agonists: what can they teach us about schizophrenia? Arch Gen Psychiatry (1999) 1.68

Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood (1999) 1.66

Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol (2002) 1.61

Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci (1989) 1.57

Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia (1992) 1.57

Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience (1980) 1.56

Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res (1974) 1.56

The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Prog Brain Res (1998) 1.55

Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest (2000) 1.51

Excitotoxicity and the NMDA receptor--still lethal after eight years. Trends Neurosci (1995) 1.51

An electron microscopic study of synapse formation, receptor outer segment development, and other aspects of developing mouse retina. Invest Ophthalmol (1968) 1.47

Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth (2013) 1.47

Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ (2008) 1.44

Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients. Br J Haematol (1996) 1.44

Glutamate: a new target in schizophrenia? Trends Pharmacol Sci (1990) 1.43

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiatry (1993) 1.41

Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science (1969) 1.39

[International diffusion of clinical trials carried out in Spain. An analysis based on their publication in scientific journals]. Med Clin (Barc) (1994) 1.39

[An analysis of Spanish biomedical journals by the impact factor]. Med Clin (Barc) (1992) 1.39

The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience (1987) 1.37

Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37

Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res (1971) 1.37

Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol (2001) 1.37

Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J (1996) 1.36

Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science (1983) 1.36

Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis (2001) 1.36

Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol (2001) 1.35

PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res (1994) 1.34

Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia (2003) 1.30

Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A (1996) 1.30

Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25

Excitotoxic mechanisms of epileptic brain damage. Adv Neurol (1986) 1.24

Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis (2000) 1.24

Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol (1999) 1.24

Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol (2000) 1.23

Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol (1999) 1.23

A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron (1993) 1.22

Central nervous system involvement in mantle cell lymphoma. Ann Oncol (2007) 1.22

Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci U S A (2000) 1.21

N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A (1999) 1.20

The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res (1987) 1.20

Cholinomimetics produce seizures and brain damage in rats. Experientia (1983) 1.18

Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci (1998) 1.18

The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol (2006) 1.18

Cloning of a gene involved in rRNA precursor processing and 23S rRNA cleavage in Rhodobacter capsulatus. J Bacteriol (1994) 1.16

p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood (1996) 1.16

Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res (1979) 1.15

Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature (1970) 1.15

Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J (1986) 1.14

Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. An electron microscopic study. J Neuropathol Exp Neurol (1971) 1.13

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem (2001) 1.13

Residual splenic function after laparoscopic splenectomy: a clinical concern. Arch Surg (1998) 1.12

Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12

"Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull (1983) 1.11

Effects of lactate and pyruvate on glucose deprivation in rat hippocampal slices. Neuroreport (1994) 1.11

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol (1990) 1.11

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry (2000) 1.11

Chronic lymphocytic leukemia: a changing natural history? Leukemia (1997) 1.10

Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J (1995) 1.08

Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci (1989) 1.08

An epidemiological comparison of pain complaints in the general population of Catalonia (Spain). Pain (1999) 1.08

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res (2001) 1.07

The epileptogenic effect of tranexamic acid. J Neurol (1999) 1.07

CNS involvement in mantle-cell lymphoma. J Clin Oncol (1996) 1.05

Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol (1969) 1.05

Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes. J Biol Chem (1986) 1.05

Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther (1994) 1.04

Antiepileptic drugs and the developing brain. Cell Mol Life Sci (2006) 1.04